Spotlight On Three Promising Penny Stocks In September 2026

Over the last 7 days, the U.S. market has dipped by 1.6%, but it remains up by 12% over the past year with anticipated earnings growth of 17% annually in the coming years. For investors seeking opportunities beyond well-known stocks, penny stocks—often smaller or newer companies—can still offer intriguing prospects despite their somewhat outdated name. This article explores three penny stocks that stand out for their financial strength and potential to capitalize on current market conditions.

Let's take a closer look at a couple of our picks from the screened companies.

Solowin Holdings (AXG)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Solowin Holdings is an investment holding company that operates as a fintech company in Hong Kong, with a market cap of $393.93 million.

Operations: The company generates revenue from two main segments: Ai Tokens, contributing $22.20 million, and Digital Asset Tokens, accounting for $5.84 million.

Market Cap: $393.93M

Solowin Holdings, with a market cap of US$393.93 million, operates in the fintech sector and has seen its revenue grow to US$28.05 million for the year ending March 2026, up from US$2.82 million previously. Despite this growth, it reported a net loss of US$13.17 million and faces challenges like delayed SEC filings. Recent developments include launching AXG Digital in the U.S., focusing on AI infrastructure and high-performance computing with plans for significant capacity expansion by 2028. The company is also advancing its AI-native financial platform through strategic partnerships and regulatory milestones such as stablecoin issuance licensing in Bahrain.

• Unlock comprehensive insights into our analysis of Solowin Holdings stock in this financial health report.
• Gain insights into Solowin Holdings' historical outcomes by reviewing our past performance report.

CuriosityStream (CURI)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: CuriosityStream Inc. is a media and entertainment company that offers factual content across various platforms, with a market cap of $165.55 million.

Operations: The company generates $75.96 million in revenue from its media and entertainment operations focused on factual content.

Market Cap: $165.55M

CuriosityStream, with a market cap of US$165.55 million, has recently turned profitable and reported significant earnings growth. For the second quarter ending June 30, 2026, it achieved a net income of US$8.88 million on sales of US$23.25 million, up from previous periods. The company remains debt-free but faces challenges with short-term liabilities exceeding its short-term assets by US$4.5 million. Despite high volatility in share price and a dividend not well-covered by earnings or cash flow, CuriosityStream's stock is trading significantly below fair value estimates and analysts anticipate substantial price appreciation potential at 89.8%.

• Click to explore a detailed breakdown of our findings in CuriosityStream's financial health report.
• Examine CuriosityStream's earnings growth report to understand how analysts expect it to perform.

Clover Health Investments (CLOV)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Clover Health Investments, Corp. offers Medicare Advantage plans in the United States and has a market cap of approximately $2.71 billion.

Operations: The company's revenue is primarily derived from its insurance segment, totaling $2.48 billion.

Market Cap: $2.71B

Clover Health Investments, with a market cap of US$2.71 billion, has shown improved financial performance despite being unprofitable. Recent earnings results for Q2 2026 revealed a revenue increase to US$743.17 million and a net income of US$28 million, reversing the previous year's loss. The company has no debt and maintains sufficient cash runway for over three years due to positive free cash flow growth. However, significant insider selling in the past quarter raises concerns about internal confidence. Trading at 86.5% below estimated fair value suggests potential undervaluation compared to peers in the industry.

• Navigate through the intricacies of Clover Health Investments with our comprehensive balance sheet health report here.
• Assess Clover Health Investments' future earnings estimates with our detailed growth reports.

Key Takeaways

• Gain an insight into the universe of 322 US Penny Stocks by clicking here.
• Contemplating Other Strategies? We've found 7 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com